Dye Solutions Based on Lutein and Zeaxanthin: In Vitro and In Vivo Analysis of Ocular Toxicity Profiles

References

• Rodrigues EB, Penha FM, Furlani B, Meyer CH, Maia M, Farah ME. Historical aspects and evolution of the application of vital dyes in vitreoretinal surgery and chromovitrectomy. Dev Ophthalmol 2008;42:29–34
   Google Scholar
• Farah ME, Maia M, Rodriguez EB. Dyes in Ocular Surgery: principles for use in chromovitrectomy. Am J Ophthalmol 2009;148:332–340
   PubMed Web of Science ®Google Scholar
• Da Mata AP, Burk SE, Foster RE, Riemann CD, Petersen MR, Nehemy M, et al. Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair. Ophthalmology 2004;111:2246–2253
   PubMed Web of Science ®Google Scholar
• Farah ME, Maia M, Penha FM. The use of vital dyes during vitreoretinal surgery – chromovitrectomy. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, eds. Retinal pharmacotherapy. Philadelphia, PA: Saunders Co; 2010. pp 331–335
   Google Scholar
• Rodrigues EB, Maia M, Meyer CH, Penha FM, Dib E, Farah ME. Vital dyes for chromovitrectomy. Curr Opin Ophthalmol 2007;18:179–187
   PubMed Web of Science ®Google Scholar
• Rodrigues EB, Costa EF, Penha FM, Melo GB, Bottós J, Dib E, et al. The use of vital dyes in ocular surgery. Surv Ophthalmol 2009;54:576–617
   PubMed Web of Science ®Google Scholar
• Rodrigues EB, Penha FM, de Paula Fiod Costa E, Maia M, Dib E, Moraes M Jr, et al. Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 2010;149:265–277
   PubMedGoogle Scholar
• Enaida H, Ishibashi T. Brilliant blue in vitreoretinal surgery. Dev Ophthalmol 2008;42:115–125
   PubMedGoogle Scholar
• Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006;26:631–636
   PubMed Web of Science ®Google Scholar
• Yuen D, Gonder J, Proulx A, Liu H, Hutnik C. Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green. Am J Ophthalmol 2009;147:251–259
   PubMed Web of Science ®Google Scholar
• Maia M, Haller JA, Pieramici DJ, Margalit E, de Juan E Jr, Farah ME, et al. Retinal pigment epithelium abnormalities after intravitreal injection of ICG to aid peeling of the internal limiting membrane in human eyes. Retina 2004;24:157–160
   PubMed Web of Science ®Google Scholar
• Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G, et al. Effects of intravitreal indocyanine green injection in rabbits. Retina 2004;24:69–79
   PubMed Web of Science ®Google Scholar
• Rodrigues EB, Penha FM, Farah ME, de Paula Fiod Costa E, Maia M, Dib E, et al. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 2009;29:497–510
   Google Scholar
• Yemelyanov AY, Katz NB, Bernstein PS. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 2001;72:381–392
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Lott MN, Marcus DM. The macular xanthophylls. Surv Ophthalmol 2005;50:183–193
   PubMed Web of Science ®Google Scholar
• Nolan JM, Stack J, Mellerio J, Godhinio M, O'Donovan O, Neelam K, et al. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res 2006;31:199–213
   PubMed Web of Science ®Google Scholar
• Snodderly DM, Handelman GJ, Adler AJ. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 1991;32:268–279
   PubMed Web of Science ®Google Scholar
• Gale CR, Hall NF, Phillips DI, Martyn CN. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 2001;108:1992–1998
   PubMed Web of Science ®Google Scholar
• Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998;82:907–910
   PubMed Web of Science ®Google Scholar
• Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113:1518–1523
   PubMed Web of Science ®Google Scholar
• Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology 2003;110:51–60
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001;42:235–240
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272:1413–1420
   PubMed Web of Science ®Google Scholar
• Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. Macular pigment and age related macular degeneration. Br J Ophthalmol 1999;83:867–877
   PubMed Web of Science ®Google Scholar
• Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci 2001;42:1873–1881
   PubMed Web of Science ®Google Scholar
• Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. An one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997;65:57–62
   PubMed Web of Science ®Google Scholar
• Sousa-Martins D, Maia M, Moraes M, Lima-Filho AA, Rodrigues EB, Chen J, et al. Use of Lutein and Zeaxanthin alone or combined with brilliant blue to identify intraocular structures intraoperatively. Retina 2012;32:1328–1336
   Google Scholar
• Maia M, Furlani BA, Souza-Lima AA, Martins DS, Navarro RM, Belfort R Jr. LUTEIN: a new dye for chromovitrectomy. Retina 2014;34:262–272
   PubMed Web of Science ®Google Scholar
• Caseli L, Sousa-Martins D, Maia M, Lima-Filho AA, Rodrigues EB, Belfort R Jr. An intraocular dye solution based on lutein and zeaxanthin in a surrogate internal limiting membrane model: a Langmuir monolayer study. Colloids Surf B Biointerfaces 2013;107:124–129
   Google Scholar
• Baszkin A. Molecular recognition on the supported and on the air/water interface-spread protein monolayers. Adv Colloid Interface Sci 2006;128–130:111–120
   Google Scholar
• Pavinatto FJ, Caseli L, Oliveira ON. Chitosan in nanostructured thin films. Biomacromolecules 2010;11:1897–1908
   PubMed Web of Science ®Google Scholar
• Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophtahlmol Vis Sci 2001;42:2942–2948
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer-cultures. Anal Biochem 1986;159:109–113
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, et al. AREDS 2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology 2012;119:2282–2289
   PubMed Web of Science ®Google Scholar
• Steel DH, Charles S. Vitrectomy fluidics. Ophthalmologica 2011;226:27–35
   PubMed Web of Science ®Google Scholar
• Lo HM, Tsai YJ, Du WY, Tsou CJ, Wu WB. A naturally occurring carotenoid, lutein, reduces PDGF and H2O2 signaling and compromised migration in cultured vascular smooth muscle cells. J Biomed Sci 2012;19:18
   Google Scholar
• Maia M, Penha F, Rodrigues EB, Príncipe A, Dib E, Meyer CH, et al. Effects of subretinal injection of patent blue and trypan blue in rabbits. Curr Eye Res 2007;32:309–317
   PubMed Web of Science ®Google Scholar
• Sujak A, Gabrielska J, Grudziński W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys 1999;371:301–307
   PubMed Web of Science ®Google Scholar
• Margrain T, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 2004;23:523–531
   PubMed Web of Science ®Google Scholar